Additional studies are required to further evaluate whether the role of UGT2B17 in PCa extends beyond androgen catabolism and signalling, and to decipher the regulatory mechanisms prevailing in normal prostate, primary PCa tumours and throughout metastatic dissemination. The gene discussed is UGT2B17; the disease is posterior cortical atrophy.